Leflunomide in Mild COVID-19 Patients
NCT04361214
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
11
Enrollment
OTHER
Sponsor class
Stopped
Terminated by PI
Conditions
COVID-19
Interventions
DRUG:
Leflunomide
Sponsor
University of Chicago